• FirefoxInstall the new Firefox »
  •  Dow Down 1.54% Nasdaq Down 1.11%

    TG Therapeutics, Inc. (TGTX)

    -NasdaqCM
    15.16 Down 0.43(2.76%) 4:00PM EST
    |After Hours : 15.16 0.00 (0.00%) 4:40PM EST
    Add to Portfolio
    Prev Close:15.59
    Open:15.51
    Bid:14.51 x 300
    Ask:15.74 x 100
    1y Target Est:23.20
    Beta:-0.8
    Next Earnings Date:N/A
    Day's Range:15.00 - 15.75
    52wk Range:4.42 - 18.88
    Volume:368,740
    Avg Vol (3m):620,483
    Market Cap:666.49M
    P/E (ttm):N/A
    EPS (ttm):-1.35
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for TGTX

    Comparison

    Symbol% ChgMkt Cap
    TGTXDown 2.76%666.49M
    BIIBDown 1.87%97.98B
    CELGDown 2.22%94.49B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):4,497.93
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.36
    Quarterly EPS Est (Dec-14) :-0.26
    Mean Recommendation*:1.6
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    TG Therapeutics, Inc., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of various pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback